- Home
- ELDN vs TWN Comparison
ELDN vs TWN Comparison
Compare ELDN & TWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- TWN
- Stock Information
- Founded
- ELDN 2004
- TWN 1986
- Country
- ELDN United States
- TWN Hong Kong
- Employees
- ELDN N/A
- TWN N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- TWN Trusts Except Educational Religious and Charitable
- Sector
- ELDN Health Care
- TWN Finance
- Exchange
- ELDN Nasdaq
- TWN Nasdaq
- Market Cap
- ELDN 178.4M
- TWN 193.5M
- IPO Year
- ELDN N/A
- TWN N/A
- Fundamental
- Price
- ELDN $2.72
- TWN $42.74
- Analyst Decision
- ELDN Strong Buy
- TWN
- Analyst Count
- ELDN 2
- TWN 0
- Target Price
- ELDN $12.50
- TWN N/A
- AVG Volume (30 Days)
- ELDN 198.6K
- TWN 20.1K
- Earning Date
- ELDN 08-18-2025
- TWN 01-01-0001
- Dividend Yield
- ELDN N/A
- TWN 1.10%
- EPS Growth
- ELDN N/A
- TWN N/A
- EPS
- ELDN N/A
- TWN N/A
- Revenue
- ELDN N/A
- TWN N/A
- Revenue This Year
- ELDN N/A
- TWN N/A
- Revenue Next Year
- ELDN N/A
- TWN N/A
- P/E Ratio
- ELDN N/A
- TWN N/A
- Revenue Growth
- ELDN N/A
- TWN N/A
- 52 Week Low
- ELDN $2.30
- TWN $25.22
- 52 Week High
- ELDN $5.54
- TWN $41.51
- Technical
- Relative Strength Index (RSI)
- ELDN 35.43
- TWN 74.67
- Support Level
- ELDN $2.76
- TWN $41.42
- Resistance Level
- ELDN $2.90
- TWN $43.11
- Average True Range (ATR)
- ELDN 0.16
- TWN 0.64
- MACD
- ELDN -0.03
- TWN 0.19
- Stochastic Oscillator
- ELDN 4.39
- TWN 93.86
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About TWN Taiwan Fund Inc. (The)
Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.